The angiotensin receptor blocker valsartan can improve left ventricular filling in patients with mild or moderate essential hypertension and impaired diastolic function. However the role of the renin-angiotensin-aldosterone system in the treatment of left ventricle diastolic dysfunctions current under investigation. Although diastolic heart failure has a move favourable prognosis, the mortality risk in older patients may not differ.